Search

Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From The Doctor’s Advocate

Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.

December 03, 2025, Physicians Practice
Top 7 Considerations for Telehealth in 2026
The clinical and regulatory landscape for telehealth continues to evolve rapidly. Medical and dental practices face a wide range of changing regulations, complicated payment issues, and growing patient safety risks. Julie Ritzman, MBA, CPHRM, Senior Vice President of Patient Safety and Risk Management at The Doctors Company, provides seven telehealth considerations for clinicians heading into 2026.

December 05, 2024, Inside Medical Liability Online
Incidental Findings Can Lead to Malpractice Claims: Practice Protocols Can Help
If the ordering practitioner does not follow up, an incidental finding may lead to patient harm and result in a malpractice claim. The Doctors Company has completed a new analysis of medical malpractice claims against our members in which an incidental finding was identified as a contributing factor.

The Doctors Company Assists Members Impacted by Hurricane Helene
Due to disruption to member medical practices from Hurricane Helene and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee, with Florida extending from September 26, 2024, to November 26, 2024.

Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Stay in the Know

Our e-newsletters feature timely articles, videos, and guides on a range of patient safety topics.

The Doctor’s Practice

Medical Icon Clipart Subscribe

The Dentist’s Advocate

Tooth Clipart Subscribe

The Practitioner

Man and Two Women Doctors Clipart Subscribe